Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

NCT04883242 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Multiple Myeloma
Refractory Multiple Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Dexamethasone
BIOLOGICAL: Isatuximab
DRUG: Pomalidomide
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Skeletal Survey X-Ray
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Magnetic Resonance Imaging

Sponsor

University of Washington

Collaborators

Genzyme, a Sanofi Company